OakChart

Bon Natural Life Ltd

BONBasic Materials·Specialty Chemicals·China·Nano·NASD·Nov 11 • 12:36 PM ET

1.110.00 (0.00%)
2026-11-11 18:42 CET
Market cap
9.07 USD m
Revenue, TTM
18.82 USD m
Net income, TTM
-11.37 USD m
Free cash flow, TTM
2.20 USD m
EPS diluted, TTM
-2.30
P/E
-
Compare

Price

BON against its 20, 50 and 200-day averages
2050200
1.001.201.401.6060K120KMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BONclose 1.1120-day 1.1350-day 1.15200-day 1.271.1152w low

44.5% under the 52-week high of 2.00 on 11 Nov 2025. 52-week low 0.95 on 1 Oct 2026. Last 15 sessions, 12.5% high to low

Profile

BON
52-week range, 15% of the way up
0.952.00

Bon Natural Life Ltd. engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants which are widely used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. It offers fragrance compounds, health supplemental powder drinks, and bioactive food ingredients. The company was founded by Yong Wei Hu in 2006 and is headquartered in Xi'an, China.

Employees96
IPOJun 24, 2021
Beta-0.25
ATR, 14d0.05
Rel volume0.61
Short float0.23%
Insider own26.47%
Inst own0.48%

Snapshot

6 groups

Valuation

Index-
Market Cap9.07M
Enterprise Value12.22M
Income-11.37M
Sales18.82M
Book/sh6.22
Cash/sh1.12
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees96
IPOJun 24, 2021

Ratios

P/E-
Forward P/E-
PEG-
P/S0.48
P/B0.18
P/C0.99
P/FCF4.12
EV/EBITDA-
EV/Sales0.65
Quick Ratio1.31
Current Ratio1.83
Debt/Eq0.24
LT Debt/Eq0.03
Option/ShortNo / Yes

Earnings

EPS (ttm)-2.30
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y-14.54% 0.49%
EPS Y/Y TTM-173.30%
Sales Y/Y TTM-12.92%
EPS Q/Q-400.04%
Sales Q/Q1.86%
Earnings-
EPS/Sales Surpr.- -

Ownership

Insider Own26.47%
Insider Trans0.00%
Inst Own0.48%
Inst Trans0.89%
ROA-14.98%
ROE-21.79%
ROIC-21.71%
Gross Margin22.10%
Oper. Margin-45.50%
Profit Margin-60.39%
SMA20-1.69%
SMA50-3.28%
SMA200-12.89%
Trades-

Technical

Shs Outstand6.13M
Shs Float6.01M
Short Float0.23%
Short Ratio1.54
Short Interest0.01M
52W High2.00 -44.50%
52W Low0.95 16.84%
Volatility2.99% 3.88%
ATR (14)0.05
RSI (14)41.74
Beta-0.25
Rel Volume0.61
Avg Volume8.82K
Volume2,785

Performance

Perf Week-0.89%
Perf Month-0.89%
Perf Quarter-3.39%
Perf Half Y-9.02%
Perf YTD-30.19%
Perf Year-43.37%
Perf 3Y-98.94%
Perf 5Y-99.93%
Perf 10Y-
Recom-
Target Price-
Prev Close1.11
Price1.11
Change %0.00%

Peers

Mkt cap
TickerCompanyMkt cap
SXTSensient Technologies Corp5.09B
BCPCBalchem Corp5.46B
IFFInternational Flavors & Fragrances Inc20.58B
UPCUniverse Pharmaceuticals INC7.76M
BYAHPark Ha Biological Technology Co Ltd3.48M
SXTCChina SXT Pharmaceuticals Inc2.01M
FAMIFarmmi Inc3.94M
TANHTantech Holdings Ltd25.55M
INGRIngredion Inc5.69B
NATRNature's Sunshine Products Inc179.35M

News

latest 14 of 146
  • BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives (PR Newswire)
  • BON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics Market (PR Newswire)
  • BON Partners with Chang'an Pilot to Launch World-Class Joint Laboratory for Natural Ingredient Bio-manufacturing (PR Newswire)
  • BON Unveils Kombucha-Inspired Product, Inks $12 Million Strategic Sales Agreement with Qingshengyuan (PR Newswire) +8.16%
  • BON Announced Next-Gen of Tea Pigment Digestive Health Products and Cooperation Agreement of US$26 Million with Beijing Huahai Keyuan (PR Newswire)
  • Loading…
  • BON Announces $18 Million Cooperation Agreement for Innovative Second-Generation Apple Series Health Products (PR Newswire) +24.68%
  • BON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D Platform (PR Newswire)
  • BON Announces Reciept of Nasdaq Compliance Letter (PR Newswire)
  • BON Launches AI-Powered New Drug Research and Development (PR Newswire)
  • BON Announces $22 Million Distribution Agreement for Weight Loss Products with Beijing Huahai Keyuan Technology Co., Ltd (PR Newswire)
  • BON Announces Nasdaq Compliance (PR Newswire)
  • Bon Announces Breakthrough Order for $16 Million Gut-Health Products (PR Newswire) +18.70%
  • Bon Natural Life announces distribution agreement with Merrill-Youli Trading (TipRanks)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2023S12023-09-1160.000-58.54314.15--
2022S22023-02-1011080.000109.8416.2216.491
2022S12022-08-0175.00072.50075.97813.6915.831

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2022FY185--29.90-

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2023S2S2023-12-2310019.8819.8819.88
2023S2S2023-12-2210019.8819.8819.88
2023S2S2023-12-2110019.8819.8819.88
2023S2S2023-12-2010019.8819.8819.88
2023S2S2023-12-1910019.8819.8819.88
2023S2S2023-12-1810019.8819.8819.88
2023S2S2023-12-1710019.8819.8819.88
2023S2S2023-12-1610019.8819.8819.88
2023S2S2023-12-1310019.8819.8819.88
2023S2S2023-12-1210019.8819.8819.88
2023S2S2023-12-1110019.8819.8819.88
2023S2S2023-12-1010019.8819.8819.88
2023S2S2023-12-0910019.8819.8819.88
2023S2S2023-12-0610019.8819.8819.88

Estimate history

EPS, annual6.70577.24590.838137.78185.7281249.165103.568-0.724
Period20182019202020212022202320242025
EPS, quarterly
Period
Sales, annual10.78216.39618.2225.49529.90929.52223.84518.671
Period20182019202020212022202320242025
Sales, quarterly
Period
Shares, annual0.0330.0330.0330.0330.0340.0050.0858.129
Period20182019202020212022202320242025
Shares, quarterly
Period

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue18.8218.6723.8429.5229.9125.4918.2216.4010.78
Cost of Goods Sold Incl. D&A14.6614.7916.7320.6820.4818.3813.0211.118.41
Gross Profit4.163.887.118.849.427.115.205.282.37
Selling, General and Administrative Excl. Other12.725.505.242.902.881.711.732.111.77
Research and Development1.440.751.620.300.420.250.210.520.56
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-8.56-1.621.875.946.545.403.473.180.60
Interest Expense0.450.370.300.240.450.420.330.330.29
Unusual Expense1.920.000.000.00-0.020.050.00-0.01-0.02
Net Income Before Taxes-11.23-1.710.725.577.515.433.652.990.41
Income Taxes0.160.340.351.001.270.820.560.430.18
Consolidated Net Income-11.39-2.050.364.576.244.613.102.560.22
Net Income From Continuing Operations-11.37-1.990.424.616.244.593.032.570.22
Net Income-11.37-1.990.404.606.244.593.032.570.22
EPS (Recurring)-1.65-0.72103.571,249.16185.33138.7390.8477.136.26
EPS (Basic, Before Extraordinaries)-2.30-0.72104.221,257.16186.51137.7890.8477.256.71
EPS (Diluted)-2.30-0.72103.571,249.16185.73137.7890.8477.256.71
EBITDA-7.12-0.343.157.126.915.693.703.400.83
Non-Operating Income (Expense)-0.210.28-0.85-0.131.400.490.520.140.07
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.984.161.040.100.130.320.16--
Price To Earnings Ratio--0.63------
Price To Sales Ratio0.420.290.010.010.612.77---
Gross Margin22.1020.7729.8229.9431.5127.9028.5532.2222.01
Operating Margin-45.50-8.697.8620.1121.8721.1819.0319.375.58
Net Margin-60.39-10.681.6715.5720.8618.0116.6115.702.07
Shares Outstanding8.178.130.080.000.030.030.030.030.03
Market Capitalization9.079.074.20------

Income statement, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S22023S12022S2
Total Revenue8.1010.727.9513.6610.1815.3714.1516.22
Cost of Goods Sold Incl. D&A5.918.756.049.527.2211.259.4310.83
Gross Profit2.191.971.914.142.974.124.725.39
Selling, General and Administrative Excl. Other8.843.881.622.352.881.191.731.64
Research and Development0.780.660.100.730.890.170.130.26
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-6.65-1.910.281.790.082.932.993.75
Interest Expense0.250.200.160.160.140.060.180.17
Unusual Expense1.920.000.000.000.000.000.00-0.04
Net Income Before Taxes-9.20-2.020.310.670.052.942.614.42
Income Taxes0.000.160.180.260.090.490.510.70
Consolidated Net Income-9.20-2.190.140.41-0.042.452.103.71
Net Income From Continuing Operations-9.20-2.160.170.43-0.012.482.123.69
Net Income-9.20-2.160.170.41-0.012.482.123.69
EPS (Recurring)-1.29-0.790.502.57-0.2052.7459.02109.09
EPS (Basic, Before Extraordinaries)-1.51-0.790.562.57-0.2052.7459.42109.83
EPS (Diluted)-1.51-0.790.502.57-0.2052.7458.54109.83
EBITDA-5.77-1.351.012.260.893.723.383.98
Non-Operating Income (Expense)-0.380.170.19-0.960.110.07-0.190.80
Stock Option Compensation Expense0.063.920.230.240.800.080.030.06
Price To Earnings Ratio-0.6322.8928.40----
Price To Sales Ratio0.420.290.040.320.210.160.420.61
Gross Margin27.0118.3824.0030.3229.1526.8233.3433.22
Operating Margin-82.18-17.793.5713.100.8319.0821.1023.13
Net Margin-113.62-20.182.132.99-0.1016.1114.9822.74
Shares Outstanding8.178.133.760.160.060.050.040.03
Market Capitalization9.074.2024.4630.34----

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments6.270.660.110.843.610.050.290.82
Short Term Receivables11.5411.814.616.786.155.775.242.55
Inventories19.2416.049.395.815.694.512.609.40
Other Current Assets8.7111.2810.071.281.100.010.450.68
Total Current Assets45.7639.7924.1814.7216.5510.338.5813.45
Net Property, Plant & Equipment18.2715.1515.7922.1719.4314.179.503.01
Total Investments and Advances0.000.000.000.000.000.000.000.00
Long-Term Note Receivable14.730.00------
Intangible Assets6.420.780.770.370.410.140.140.15
Deferred Tax Assets0.000.000.000.000.020.050.040.04
Other Assets0.006.055.810.000.000.511.310.00
Total Assets85.1961.7746.5637.2636.4125.2019.5616.64
Short Term Debt Incl. Current Port. of LT Debt11.416.333.164.820.713.244.663.18
Accounts Payable7.643.431.400.210.381.293.223.43
Income Tax Payable4.883.682.720.581.690.850.23-0.07
Other Current Liabilities2.383.012.331.044.746.322.752.21
Total Current Liabilities26.3116.459.616.657.5311.7010.868.75
Long Term Debt0.880.970.960.522.352.481.433.35
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.000.000.00
Total Liabilities27.1917.4210.577.169.8814.1812.3012.10
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity57.5543.9135.4829.5626.0110.526.844.55
Total Shareholders Equity57.5543.9135.4829.5626.0110.526.844.55
Accumulated Minority Interest0.450.440.500.530.530.510.420.00
Total Equity58.0044.3535.9830.0926.5311.027.264.55
Total Liabilities & Stockholders Equity85.1961.7746.5637.2636.4125.2019.5616.64
Book Value Per Share7.08518.017,557.21880.22780.52315.61205.23136.45
Tangible Book Value Per Share6.29508.857,394.00869.31768.18311.38201.08132.01
Full-Time Employees969796103938781-
Price to Book Ratio0.180.14------
Return on Assets-2.710.7711.0116.9314.9013.5214.22-
Return on Equity-3.931.0514.1922.4525.1434.8845.21-
Return on Invested Capital-3.410.8912.6120.7416.1923.2831.122.83
Quick Ratio1.011.441.541.341.440.500.550.46
Current Ratio1.742.422.522.212.200.880.791.54

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-11.39-2.050.354.556.244.613.102.560.22
Depreciation1.441.291.281.180.370.290.230.230.22
Other Funds (Non Cash)10.872.362.32-6.630.01-0.220.030.030.28
Funds from Operations0.921.603.95-0.906.644.713.352.810.78
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital9.94-1.45-11.670.25-6.83-0.65-0.714.29-0.51
Income Taxes Payable2.161.270.831.56-3.630.412.661.54-0.17
Cash from Operating Activities10.860.14-7.72-0.65-0.194.052.647.100.27
Capital Expenditures-14.29-10.00-0.01-0.73-4.74-4.75-4.33-8.43-1.68
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.440.00
Purchase or Sale of Investments0.000.000.00-0.001.68-1.690.000.000.00
Purchase of Investments0.000.000.00-0.00-5.10-2.160.000.000.00
Sale Or Maturity of Investments0.000.000.000.006.780.470.000.000.00
Other Uses0.000.00-0.01-0.460.00-1.000.000.000.00
Other Sources0.000.000.000.010.000.001.330.000.00
Cash from Investing Activities-14.28-10.00-0.02-1.19-3.06-7.44-3.00-7.99-1.68
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.1310.675.602.030.0011.270.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.1310.675.602.030.0011.270.000.000.00
Proceedsfrom Stock Options0.1310.675.602.030.0011.270.000.000.00
Issuance or Reduction of Debt, Net3.374.783.15-0.882.26-5.400.390.372.02
Change in Long Term Debt0.730.630.24-1.04-0.23-1.11-0.070.431.53
Issuance of Long Term Debt1.680.970.691.130.581.420.320.431.53
Reduction of Long Term Debt-0.96-0.34-0.45-2.17-0.81-2.52-0.390.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.00-0.52-0.280.000.00
Other Financing Activities Uses0.000.000.000.000.00-0.52-0.280.000.00
Cash from Financing Activities3.5015.458.761.162.265.350.110.372.02
Exchange Rate Effect0.220.01-0.47-0.05-0.08-0.110.01-0.01-0.02
Net Change in Cash0.295.610.55-0.73-1.061.85-0.24-0.530.59
Free Cash Flow2.20-4.23-7.73-0.71-4.92-0.43-1.690.03-1.41
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow3.57--------
Deferred Taxes & Investment Tax Credit-0.000.000.000.020.03-0.01-0.010.06

Balance sheet, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S2
Cash & Short Term Investments9.186.278.890.660.720.11
Short Term Receivables10.4311.5415.0811.818.114.60
Inventories14.4719.2413.4916.0416.8516.10
Other Current Assets16.788.715.0011.282.583.36
Total Current Assets50.8745.7642.4639.7928.2624.18
Net Property, Plant & Equipment22.8918.2713.9315.1520.8121.38
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets6.446.420.740.780.991.00
Deferred Tax Assets-0.000.000.000.010.00
Other Assets0.000.000.006.050.000.00
Total Assets80.2085.1971.5861.7750.0846.56
Short Term Debt Incl. Current Port. of LT Debt10.7611.418.496.335.293.16
Accounts Payable8.597.642.053.431.281.40
Income Tax Payable5.184.882.813.682.521.30
Other Current Liabilities3.312.384.063.012.483.75
Total Current Liabilities27.8526.3117.4016.4511.599.61
Long Term Debt1.570.880.280.971.180.96
Other Liabilities0.000.000.000.000.000.00
Total Liabilities29.4227.1917.6817.4212.7610.57
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity50.7857.5553.5243.9136.6935.48
Total Shareholders Equity50.7857.5553.5243.9136.6935.48
Accumulated Minority Interest0.000.450.380.440.620.50
Total Equity50.7858.0053.9144.3537.3235.98
Total Liabilities & Stockholders Equity80.2085.1971.5861.7750.0846.56
Book Value Per Share6.227.0814.24276.45648.83755.72
Tangible Book Value Per Share5.436.2914.05271.56631.28734.53
Price to Book Ratio0.180.140.210.26--
Return on Assets-14.98-2.710.980.775.0710.97
Return on Equity-21.79-3.931.321.056.8814.13
Return on Invested Capital-17.58-3.700.310.91-0.036.79
Quick Ratio1.311.011.661.440.980.84
Current Ratio1.831.742.442.422.442.52

Cash flow, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S2
Net Income-9.20-2.190.140.39-0.042.45
Depreciation0.880.560.720.480.800.79
Other Funds (Non Cash)8.732.140.221.231.090.18
Funds from Operations0.410.521.082.111.843.44
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital6.023.92-5.37-7.94-3.73-1.91
Income Taxes Payable0.142.02-0.751.06-0.221.18
Cash from Operating Activities6.424.44-4.30-5.84-1.881.53
Capital Expenditures-4.29-10.000.00-0.01-0.00-1.17
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.01-0.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.00-0.00
Purchase of Investments0.000.000.000.000.00-0.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.00-0.010.000.00
Other Sources0.000.000.000.000.000.01
Cash from Investing Activities-4.28-10.000.00-0.02-0.00-1.17
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.1310.545.600.00-0.17
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.1310.545.600.00-0.17
Proceedsfrom Stock Options0.000.1310.545.600.00-0.17
Issuance or Reduction of Debt, Net0.363.001.780.642.51-0.59
Change in Long Term Debt-0.030.75-0.12-0.100.35-0.60
Issuance of Long Term Debt0.710.970.00-0.160.851.13
Reduction of Long Term Debt-0.74-0.22-0.120.06-0.51-1.73
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.363.1312.326.242.51-0.76
Exchange Rate Effect0.41-0.200.21-0.45-0.02-0.03
Net Change in Cash2.92-2.638.24-0.060.61-0.43
Free Cash Flow2.130.07-4.30-5.84-1.881.02
Price to Free Cash Flow3.57-----

Revenue breakdown

Bioactive Food Ingredients2024: 12.16M 2025: 7.26M
Fragrance Compounds2024: 4.94M 2025: 8.08M
Health Supplements (Solid Drinks)2024: 6.74M 2025: 3.33M
China2024: 23.54M 2025: 18.67M
Overseas2024: 301.69K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.23%0.0M6.0M9.08K
2026-10-150.26%0.0M6.0M8.75K
2026-09-300.20%0.0M6.0M8.03K
2026-09-150.15%0.0M6.0M8.04K
2026-08-310.27%0.0M6.0M13.64K
2026-08-140.39%0.0M6.0M15.46K
2026-07-310.23%0.0M6.0M16.19K
2026-07-150.13%0.0M6.0M16.13K
2026-06-300.11%0.0M6.0M19.15K
2026-06-150.15%0.0M6.0M20.41K
2026-05-290.21%0.0M6.0M18.05K
2026-05-150.47%0.0M6.0M58.61K
2026-04-300.31%0.0M6.0M60.75K
2026-04-150.52%0.0M6.0M63.40K
2026-03-310.43%0.0M6.0M64.26K
2026-03-130.49%0.0M6.0M67.06K
2026-02-27-0.0M-68.67K
2026-02-13-0.0M-34.94K
2026-01-30-0.0M-39.17K
2026-01-15-0.0M-52.12K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-09-236-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-31SEC
2026-05-153Initial statement of beneficial ownership of securities2026-04-02SEC
2026-04-233Initial statement of beneficial ownership of securities2026-04-02SEC
2026-04-103Initial statement of beneficial ownership of securities2026-04-02SEC
2026-04-103Initial statement of beneficial ownership of securities2026-04-02SEC
2026-04-103Initial statement of beneficial ownership of securities2026-04-02SEC
2026-04-103Initial statement of beneficial ownership of securities2026-04-02SEC
2026-04-103Initial statement of beneficial ownership of securities2026-04-02SEC
2026-04-103Initial statement of beneficial ownership of securities2026-04-02SEC
2026-03-196-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-11-30SEC
2026-02-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-02-17SEC
2026-01-2320-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2025-09-30SEC
2025-12-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-10SEC
2025-11-256-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-11-25SEC
2025-11-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-11-14SEC
2025-11-10F-3/ASEC
2025-10-16F-3Registration statement for specified transactions by certain foreign private issuersSEC
2025-09-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-09-29SEC
2025-09-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-09-09SEC
2025-08-056-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-08-04SEC
2025-07-216-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-07-21SEC
2025-07-116-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-07-11SEC
2025-07-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-07-02SEC
2025-06-166-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-06-16SEC
2025-06-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-06-03SEC
2025-05-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-05-22SEC
2025-05-166-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-05-16SEC
2025-05-056-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-05-02SEC
2025-04-24UPLOADUpload SubmissionSEC
2025-04-236-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-04-23SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
XTX Topco Ltd0.19%
CITADEL ADVISORS LLC0.16%
TWO SIGMA SECURITIES, LLC0.13%
UBS Group AG0.01%
Caitong International Asset Management Co., Ltd0.00%
OSAIC HOLDINGS, INC.0.00%

Funds

Fund% owned
WisdomTree International SmallCap Dividend Fund0.56%
WisdomTree Dynamic International SmallCap Equity Fund0.21%
WisdomTree Europe SmallCap Dividend Fund0.10%
Avantis International Equity ETF0.03%
Avantis International Equity Fund0.02%

OakChart. BON. Cached 15 minutes.

Some panels did not load: ratings, insider.